84-1012-48 Transforming Growth Factor beta (Latency-associated Peptide, TGFb, LAP) 1mg T8250-12

※お見積書はカートで印刷できます

冷凍

特徴

  • Transforming growth factor-beta (TGFb) family of proteins has potent hematopoietic regulatory properties ranging from effects on the growth and differentiation of primitive stem cells to the differentiated functions of mature cells.
  • Although most reports have described the inhibitory activities of TGF-beta on hematopoiesis, recent evidence supports the concept that TGF-beta can have both inhibitory and stimulatory actions on these systems.
  • These differences depend on the differentiation state of the target cell and the other cytokines interacting with the cell.
  • Furthermore, TGF-beta has direct bidirectional effects on cell surface expression of many cytokine receptors suggesting that it is part of the mechanism of action of TGF-beta.
  • Applications:Suitable for use in ELISA, Western Blot, Immunohistochemistry, Immunocytochemistry and Neutralization.
  • Other applications have not been tested.
  • Recommended Dilutions:Western Blot: 1ug/ml using Recombinant Human LAP TGF-beta 1Immunohistochemistry: 5-15ug/ml using immersion fixed paraffin-embedded sections of human prostate cancer tissueImmunocytochemistry: 5-15ug/ml using immersion fixed human peripheral blood mononuclear cells (PBMCs) Neutralization: Measured by its ability to neutralize LAP TGF‑ beta 1 inhibition of TGF‑ beta 1 growth inhibition in the HT‑2 mouse T cell line.
  • Tsang, M.
  • et al.
  • (1995) Cytokine 7:389.
  • The Neutralization Dose (ND50) is typically 15-30ug/mL in the presence of 125ng/mL Recombinant Human LAP TGF‑ beta 1 and 0.25ng/mL TGF‑ beta 1
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C.
  • Reconstitute with sterile PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:1mg
  • Host:goat
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein G affinity chromatography. Endotoxin: <0.1EU/ug (LAL)
  • Form:Supplied as a lyophilized powder in PBS, pH 7.5, 5% trehalose. Reconstitute with sterile 1ml PBS
  • Specificity:Recognizes human LAP (TGF-beta 1). Specific for the LAP derived from the TGF-beta 1 precursor but does not react with LAP from the TGF-beta 2 precursor.
  • Isotype:IgG
  • Calc Applications Abbrev:E IC IHC N WB
  • Calc Crossreactivity:Hu
  • Immunogen:Recombinant protein corresponding to Leu30-Ser390 from human LAP (TGF-beta 1), expressed in CHO cells and S. frugiperda insect ovarian cell line Sf 21.
  • Shelf Life:1year
  • Swiss Prot Number:P01137
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1012-48
型番
T8250-12
入り数
1個
標準価格
273,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る